EICHOR
● Active Not Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Condition: Diabetic Retinopathy · Sponsor: Boehringer Ingelheim
About this study
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find out whether a medicine called BI 764524 helps people with diabetic retinopathy. The study also aims to find a suitable treatment plan for BI 764524. Participants are put into 5 groups by chance. Participants in groups 1, 2, and 3 get BI 764524. Over 1 year, they get a different number of injections of the same dose of BI 764524 injected into 1 eye. During some visits, participants may get a sham control, which is done like an eye injection but without a needle, so that participants will not know how many injections of BI 764524 they received. Participants in group 4 only get a sham control. Participants in group 5 (only in the USA) get aflibercept or sham injections during some visits. Aflibercept is a medicine already used to treat diabetic retinopathy. Participants are in the study for one and a half years. During this time, they visit the study site at least 16 times. During this time, doctors regularly do eye exams and visual tests to assess the severity of participants' eye condition. After 1 year of treatment, researchers look at the number of participants with eye improvements. To do so, they compare eye damage and certain severe eye problems between the groups of participants. The doctors also regularly check participants' health and take note of any unwanted effects.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (84)
| Associated Retina Consultants, Ltd. | Phoenix, Arizona, United States | — |
| California Retina Consultants-Bakersfield-65523 | Bakersfield, California, United States | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills, California, United States | — |
| Retinal Diagnostic Center | Campbell, California, United States | — |
| The Retina Partners | Encino, California, United States | — |
| Lugene Eye Institute | Glendale, California, United States | — |
| Retina Associates of Southern California | Huntington Beach, California, United States | — |
| Byers Eye Institute | Palo Alto, California, United States | — |
| California Eye Specialists Medical Group Inc | Pasadena, California, United States | — |
| Retinal Consultants Medical Group | Sacramento, California, United States | — |
| Retinal Consultants Medical Group | Sacramento, California, United States | — |
| California Retina Consultants-Santa Maria-65510 | Santa Maria, California, United States | — |
+ 72 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06321302